Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Servei de Radiofísica i Radioprotecció. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Radiother Oncol. 2020 Oct;151:176-181. doi: 10.1016/j.radonc.2020.08.001. Epub 2020 Aug 7.
To determine how ESTRO can collaborate with Radiation Oncology National Societies (NS) according to its mission and values, and to define the new roadmap to strengthen the NS network role in the forthcoming years.
The ESTRO NS committee launched a survey addressed to all European National Societies, available online from June 5th to October 30th 2018. Questions were divided into three main sections: (1) general information about NS; (2) relevant activities (to understand the landscape of each NS context of action); (3) relevant needs (to understand how ESTRO can support the NS). Eighty-nine European NS were invited to participate. Respondents were asked to rank ESTRO milestones in order of importance, indicating the level of priority to their society.
A total of 58 out of 89 NS (65.2%) from 31 European countries completed the questionnaire. The majority of NS ranked "Optimal patient care to cure cancer and to reduce treatment-related toxicity" as the highest level of priority. This aligns well with the ESTRO vision 2030 "Optimal health for all together." NS also indicated a high need for more consensus guidelines and exchange of best practices, access to high quality accredited education, implementation of the ESTRO School Core Curriculum at the national level, and defining quality indicators and standard in Radiation Oncology, improved communication and increased channelling of information.
The results of this survey will be used to strengthen the relations between ESTRO and European NS to promote and develop initiatives to improve cancer care.
根据 ESTRO 的使命和价值观,确定如何与放射肿瘤学国家学会(NS)合作,并制定新的路线图,以加强 NS 网络在未来几年的作用。
ESTRO NS 委员会向所有欧洲国家学会发起了一项在线调查,调查从 2018 年 6 月 5 日至 10 月 30 日开放。问题分为三个主要部分:(1)关于 NS 的一般信息;(2)相关活动(了解每个 NS 行动背景的情况);(3)相关需求(了解 ESTRO 如何支持 NS)。邀请了 89 个欧洲 NS 参与。受访者被要求按重要性对 ESTRO 的里程碑进行排序,并指出对其学会的优先级。
共有来自 31 个欧洲国家的 58 个 NS(65.2%)完成了问卷。大多数 NS 将“为治愈癌症和减少治疗相关毒性而提供最佳的患者护理”列为最高优先级。这与 ESTRO 2030 年的愿景“共同实现所有人的最佳健康”相一致。NS 还表示,他们非常需要更多的共识指南和最佳实践交流、高质量的认证教育、在国家层面实施 ESTRO 学校核心课程,以及定义放射肿瘤学的质量指标和标准、改善沟通和增加信息渠道。
这项调查的结果将用于加强 ESTRO 与欧洲 NS 之间的关系,以促进和发展倡议,以改善癌症护理。